Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 24586533)

1.

Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.

Chiang KC, Tsui KH, Chung LC, Yeh CN, Chang PL, Chen WT, Juang HH.

PLoS One. 2014 Feb 20;9(2):e89117. doi: 10.1371/journal.pone.0089117. eCollection 2014.

2.

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.

Int J Cancer. 2012 Jun 15;130(12):2812-23. doi: 10.1002/ijc.26284. Epub 2011 Aug 30.

PMID:
21780100
3.

L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH.

Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C676-85. doi: 10.1152/ajpcell.00180.2011. Epub 2011 Nov 23.

4.

Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.

Chiang KC, Tsui KH, Chung LC, Yeh CN, Feng TH, Chen WT, Chang PL, Chiang HY, Juang HH.

Sci Rep. 2014 Jul 1;4:5511. doi: 10.1038/srep05511.

5.

BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.

Hu XD, Meng QH, Xu JY, Jiao Y, Ge CM, Jacob A, Wang P, Rosen EM, Fan S.

Biochem Biophys Res Commun. 2011 Jan 28;404(4):903-9. doi: 10.1016/j.bbrc.2010.12.064. Epub 2010 Dec 21.

PMID:
21172304
6.

Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.

Tsui KH, Hsieh WC, Lin MH, Chang PL, Juang HH.

Prostate. 2008 May 1;68(6):610-9. doi: 10.1002/pros.20725.

PMID:
18196550
7.

Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.

Hsu JC, Zhang J, Dev A, Wing A, Bjeldanes LF, Firestone GL.

Carcinogenesis. 2005 Nov;26(11):1896-904. Epub 2005 Jun 15.

8.

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.

Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB.

Cancer Biol Ther. 2008 Aug;7(8):1288-96. Epub 2008 Aug 13.

9.

Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells.

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH.

Mol Nutr Food Res. 2011 Nov;55(11):1666-76. doi: 10.1002/mnfr.201100328. Epub 2011 Sep 21.

PMID:
21936051
10.

Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.

Tsui KH, Lin YF, Chen YH, Chang PL, Juang HH.

J Androl. 2011 Jul-Aug;32(4):383-93. doi: 10.2164/jandrol.109.009878. Epub 2010 Nov 4.

11.

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH.

J Androl. 2008 Nov-Dec;29(6):661-8. doi: 10.2164/jandrol.108.004911. Epub 2008 Jul 31.

13.

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T.

Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23.

PMID:
22266859
15.

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.

Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD.

Carcinogenesis. 2001 Aug;22(8):1271-9.

16.

Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.

Lin HP, Lin CY, Hsiao PH, Wang HD, Sheng Jiang S, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP.

PLoS One. 2013 Dec 5;8(12):e82625. doi: 10.1371/journal.pone.0082625. eCollection 2013.

17.

B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.

Lim YB, Park TJ, Lim IK.

J Biol Chem. 2008 Nov 28;283(48):33110-8. doi: 10.1074/jbc.M804255200. Epub 2008 Oct 7.

18.
19.

Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.

Wang Z, Lee HJ, Wang L, Jiang C, Baek NI, Kim SH, Lü J.

Pharm Res. 2009 May;26(5):1140-8. doi: 10.1007/s11095-009-9833-2. Epub 2009 Mar 6.

PMID:
19266268
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk